<DOC>
	<DOCNO>NCT02350283</DOCNO>
	<brief_summary>To evaluate safety efficacy Solitaire thrombectomy Chinese patient acute stroke within 12 hour symptom onset .</brief_summary>
	<brief_title>Endovascular Therapy Acute Ischemic Stroke Trial</brief_title>
	<detailed_description>This study multicenter , prospective , non-randomized double-arm pilot trial . Patients acute ischemic stroke meet inclusion criterion would follow 90 day upon enrollment . There 150 intervention patient enrol . Patients agree participate observation refuse intervention various reason assign medical arm . The main reason refusal intervention expect financial , cost intervention device far exceed hospitalization pharmaceutical agent China . Not patient afford insurance pay device . We expect two third patient agree participate study refuse intervention . These patient expect similar demographic intervention patient . Although patient selection bias inevitable design , believe design appropriate pilot study critical provide miss natural history data Chinese population future trial design . The intervention patient treat mechanical recanalization Solitaire within 12 hour stroke onset plus standard medical therapy . The medical arm treat standard medical therapy alone . During trial , multiple indicator assess patient baseline , 24hours,14days ( discharge , whichever occur first ) 90 day . Primary efficacy endpoint functional independence define modified Rankin Scale ( mRS ) score ≤ 2 90 day function improvement mRS shift analysis.Primary procedure efficacy endpoint arterial recanalization occlude target vessel measure Thrombolysis Cerebral Infarction ( TICI ) score equal superior 2b right follow use Study Device . Primary safety endpoint systematicICH 24 ±3hrs post procedure.The secondary endpoint include : rate device-related procedure relate Serious Adverse Events ( SAEs ) 14 day discharge ; volume cerebral infarction measure CT scan 24 ±3hrs post procedure ; arterial reperfusion measure reperfusion ratio CT scan 24 ±3hrs post procedure ; infarction subject achieve TICI 2b‐3 reperfusion without intracranial hemorrhage ; death due cause 14days discharge 90 day ; change NIHSSat 24±3hrs post procedure ; change NIHSS 14 day discharge post procedure ; change NIHSSat 90 ± 7days ; quality life 90± 7days ; proportion patient suffer Safety Outcome : proportion patient composite : ( ) symptomatic intracranial hemorrhage ( ii ) major bleed due femoral artery access complication include groin hematoma , retroperitoneal hematoma ( iii ) contrast nephropathy ; economic ( cost-effectiveness ) analysis ; evaluation waiver/deferral consent process ; total radiation dose ( CT , CTA , angiography ) report continuous measure ; proportion patient malignant MCA infarction ; proportion patient undergo hemicraniectomy . Because substantial number patient intervention group expect intracranial atherosclerosis , subgroup analysis also carry group patient . The clinical outcome , final TICI score angioplasty possible stenting , symptomatic ICH ( include SAH ) immediate re-thrombosis rate include subgroup analysis .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>1 . Age 1880 year 2 . Clinical diagnosis ischemic stroke , stroke symptoms present least 30 minute significantly improve treatment 3 . No prestroke functional dependence ( prestroke Modified Rankin Score ≤ 1 ) 4 . NIHSS ≥ 8 &lt; 30 time enrollment 5 . Patient able treat within 12 hour stroke symptom onset minimum one deployment Solitaire Device . ( onset time define last time patient witness baseline ) 6 . Patient confirm symptomatic intracranial occlusion , base single phase , multiphase dynamic CTA/MRA DSA , one follow location : Carotid T/L , M1 MCA , M2MCA equivalent affect least 50 % MCA territory . 7 . Patient patient 's legally authorize representative receive information data collection mandatory , sign date Informed Consent Form . 1 . Baseline noncontrast CT DWI reveals moderate/large core define extensive early ischemic change ASPECTS 06 territory symptomatic intracranial occlusion DWI lesion volume &gt; 50ml . 2 . Other confirmation moderate large core define one three way : . On single phase , multiphase dynamic CTA : minimal collateral region great 50 % MCA territory compare pial fill contralateral side ( multiphase/dynamic CTA prefer ) OR . ii . On CT perfusion ( &gt; 8 cm coverage ) : low CBV low CBF ASPECTS &lt; 6 symptomatic MCA territory OR . iii . On CT perfusion ( &lt; 8 cm coverage ) : region low CBV low CBF &gt; 1/3 CTP image symptomatic MCA territory . 3 . Groin puncture possible within 70 minute end CTA/MRA acquisition . 4 . Seizure onset stroke . 5 . Prior stroke within last 3 month . 6 . Investigators think cause occlusion atherosclerosis 7 . Subject preexist neurological psychiatric disease would confound neurological functional evaluation . 8 . Presumed septic embolus suspicion bacterial endocarditis . 9 . Life expectancy le 90 day . 10 . Known history ICH , SAH , AVM tumor . 11 . Known disease increase bleeding risk last 3 month , e.g . severe liver disease , ulcerative gastrointestinal disease , esophageal varix , hepatic failure . 12 . Major surgery , significant trauma hemorrhagic disease past 10 day 13 . Uncompensated hypertension define systolic blood pressure &gt; 185 mm Hg diastolic blood pressure ≥110 mm Hg 3 repeat measure least 10 minute apart . 14 . Renal Failure define serum creatinine &gt; 2.0 Glomerular Filtration Rate [ GFR ] &lt; 30 . 15 . Platelet count 100,000/mm3 . 16 . Blood glucose &lt; 2.8 &gt; 22.2 mmol/l . 17 . Patients receive oral anticoagulant , e.g . warfarin sodium , coagulant response time ( INR ) &gt; 1.5 . 18 . Administration heparin within previous 48 hour APTT time exceed upper limit normal laboratory . 19 . Suspected intracranial dissection cause stroke . 20 . Clinical history , past image clinical judgment suggest intracranial occlusion chronic . 21 . No femoral pulse . 22 . Contraindications DSA examination , severe contrast allergy absolute contraindication iodinate contrast . 23 . Pregnancy ; woman childbearing potential positive urine serum beta HCG test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Acute Ischemic Stroke</keyword>
	<keyword>Endovascular therapy</keyword>
	<keyword>Solitaire</keyword>
	<keyword>Standard Medical Management</keyword>
</DOC>